The Psychedelic Pharmaceutical Market Projected to Hit $17B in Next Decade
The global market for these compounds reached $4.75 billion in 2025. Analysts project growth to $16.93 billion by 2034.
Read More
The global market for these compounds reached $4.75 billion in 2025. Analysts project growth to $16.93 billion by 2034.
Read More
This proposal introduces mandatory registration for clinics and establishes strict standards for patient monitoring.
Read More
Spravato has reached blockbuster status and treated more than 200,000 patients. Industry demand trends reveal what that growth means for
Read More
LSD, psilocybin, DMT, mescaline, and ayahuasca all produce the same neural fingerprint when their consciousness-altering effects take hold.
Read More
Here's why ketamine clinics are the infrastructure that defines the next era of psychedelic medicine — and what operators should
Read More
Companies explore a type of designer DMT that might improve on the original. Will these new compounds work? Can a
Read More
Guides and therapists have long preached the importance of psychedelic integration. But there wasn't much empirical data. Until now. A
Read More
Does Medicare cover ketamine therapy and ketamine infusions? Anything insurance related is confusing and complex. So let's break it down.
Read More
Magic mushrooms are being discovered by plenty of people, so here's what to know before trying them yourself.
Read More
Will ketamine help sleep? There are benefits, and this is what you need to know.
Read More